Table 1: Comparison of patient demographics and pretreatment features.

SurgeryRadiationHormone therapyTotal 𝑃 value

Age<0.0011
𝑁 21659129404
 Mean (SD)64.6 (7.2)70.9 (8.4)77 (8.1)69.5 (9.5)
Race, 𝑁 (%)0.482
 White161 (74.5)40 (67.8)92 (71.3)293 (72.5)
 Black14 (6.5)7 (11.9)16 (12.4)37 (9.2)
 Other3 (1.4)0 (0)1 (0.8)4 (1)
 Unknown38 (17.6)12 (20.3)20 (15.5)70 (17.3)
 Total21659129404
Gleason score, 𝑁 (%)0.372
 884 (54.2)33 (55.9)63 (48.8)180 (52.5)
 967 (43.2)22 (37.3)57 (44.2)146 (42.6)
 104 (2.6)4 (6.8)9 (7)17 (5)
 Total315559129343
PSA at diagnosis (ng/mL)<0.0011
𝑁 20857126391
 Mean (SD)10.3 (11.9)15.5 (27.1)48.2 (79.4)23.3 (50)
Fraction of positive cores<0.0011
𝑁 21459126399
 Mean (SD)50% (30%)40% (30%)60% (30%)50% (30%)

1Kruskal-Wallis Test.
2Pearson’s Chi-Square Test.
361 surgical patients had a Gleason score of <8 on biopsy but ≥8 on radical prostatectomy pathology and thus were included for analysis.